| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 256,619 | 254,995 | 236,743 | 125,119 | | Cost of Revenue | 57,476 | 60,308 | 58,632 | (8,901) | | | Gross Profit | 199,143 | 194,687 | 178,111 | 134,020 | | | Operating Expenses | | Research Development | 23,234 | 24,802 | 19,419 | 3,337 | | Selling General and Administrative | 88,238 | 87,175 | 85,760 | 57,757 | | Non Recurring | 470 | 4,775 | 81,185 | (49,705) | | Others | 3,061 | 3,221 | 1,446 | (5,570) | | | | Total Operating Expenses | 115,003 | 119,973 | 187,810 | 5,819 | | | | Operating Income or Loss | 84,140 | 74,714 | (9,699) | 128,201 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,539 | 7,512 | 42,002 | (2,086) | | Earnings Before Interest And Taxes | 85,679 | 82,226 | 32,303 | 126,115 | | Interest Expense | 11,805 | 11,805 | (30,578) | 10,278 | | Income Before Tax | 73,874 | 70,421 | 62,881 | 115,837 | | Income Tax Expense | 29,570 | 23,532 | 36,158 | 5,639 | | Minority Interest |
-
|
-
| 18,719 | (815) | | | | Net Income From Continuing Ops | 44,304 | 46,889 | 44,673 | 106,874 | | | Non-recurring Events | | Discontinued Operations | (8,532) | 18,626 | (145,184) | (306,908) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 35,772 | 65,515 | (100,511) | (200,034) | | Preferred Stock And Other Adjustments | (898) | (495) |
-
|
-
| | | Net Income Applicable To Common Shares | $34,874 | $65,020 | ($100,511) | ($200,034) |
|
2.03% Nasdaq 0.00%
Income Statement
